HOME >> BIOLOGY >> NEWS
Hemophilia therapy update: New information on investigational Factor VIII therapy development

WEBCAST INVITATION

Hemophilia Therapy Update: New Information on Investigational Factor VIII Therapy Development

Monday, December 9, 2002
12:30 1:30 EST
Loews Philadelphia Hotel, Commonwealth Hall A

AGENDA

Understanding Treatment Choices A Father's Perspective
Joe Caronna, Vice President, New Jersey Hemophilia Association, and Father of Patient with Hemophilia A

The Current Hemophilia Treatment Landscape
W. Keith Hoots, M.D., Medical Director, Gulf States Hemophilia and Thrombophilia Center, Houston, Texas

Phase II-III Antihemophilic Factor (Recombinant), Plasma/Albumin Free Method (rAHF-PFM) Clinical Trial Data
Peter Collins, M.D., M.R.C.P., Director, Arthur Bloom Haemophilia Centre, University Hospital of Wales, Cardiff, Wales

New Developments in Recombinant Factor VIII Technology
Edward D. Gomperts, M.D., Global Vice President, Medical Affairs, Baxter BioScience

Moderator: Edward D. Gomperts, M.D.

To register for the live webcast, please enter the newsroom of Baxter.com (http://www.baxter.com) and click on the "Hemophilia Therapy Update Webcast" button.

To R.SV.P. for the briefing or to receive additional information, please contact:
Nicole Christopher at 212-601-8279 or nchristopher@porternovelli.com
Sherry Marks at 212-601-8385 or smarks@porternovelli.com


'"/>

Contact: Nicole Christopher
nchristopher@porternovelli.com
212-601-8279
Porter Novelli
4-Dec-2002


Page: 1

Related biology news :

1. Hemophilia trials, other studies may herald successful gene therapies for human diseases
2. Successful Hemophilia B Gene Therapy In Dogs May Justify Human Experiments
3. Avigens Gene Therapy Approach Shows Promise In Treating Hemophilia B With Single Intramuscular Administration
4. Targeted therapy knocks out pediatric brain cancer in mice
5. New anti-inflammatory strategy for cancer therapy identified by UCSD researchers
6. Columbia research to examine gene influence on severity of peridontal disease, therapy response
7. Case for IBD combination therapy comes from research at Baylor, MIT and Hebrew University
8. The search for a kinder, gentler chemotherapy
9. Embryonic stem cell therapy shows steady benefits in rebuilding infarcted heart
10. Retroviral gene therapy? ASLV, HIV, and MLV show distinct target site preferences
11. Gene changes linked to increased eye pressure may have implications for glaucoma therapy

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/30/2019)... ... September 30, 2019 , ... Foresight Institute, a ... other transformative technologies, announced the winners for the 2019 Foresight Institute Feynman Prizes. ... Theory in nanotechnology/molecular manufacturing. , Established in 1993 and named in honor of ...
(Date:9/30/2019)... DURHAM, N.C. (PRWEB) , ... September 30, 2019 , ... ... therapy and an accepted model for studying the development and diseases of the human ... or potential activities of the progeny heart muscle cells to be clearly and easily ...
(Date:9/30/2019)... ALTO, Calif. (PRWEB) , ... ... ... Institute, a leading think tank, research, and public interest organization focused on ... prestigious Distinguished Student Prize. , The Award recognizes the College graduate or ...
Breaking Biology News(10 mins):
(Date:9/30/2019)... ... September 30, 2019 , ... The September 2019 ... Corporation , is now available online on the company’s global website. The Bridge ... X-ray diffraction, fluorescence and imaging, and presents articles, scientific papers and news reports. ...
(Date:9/24/2019)... POWAY, Calif. (PRWEB) , ... September 24, 2019 ... ... human adipose-derived stem cell company, has completed training and site qualification for clinical ... the process of recruitment and screening of potential clinical trial participants. , Clinical ...
(Date:9/17/2019)... SOMERSET, N.J. (PRWEB) , ... September 17, 2019 ... ... today announced that Julie Delaney, Director, Project and Clinical Supplies Management, Asia Pacific ... at the One Farrer Hotel, Singapore, on Sept. 25-26, 2019. , On Thursday, ...
(Date:9/17/2019)... ... 2019 , ... When a lot of researchers think of Visikol, they think ... characterization of tissues through the use of confocal and light sheet microscopy. However, over ... cell culture focused contract research organization and today offers 3D tissue imaging ...
Breaking Biology Technology:
Cached News: